[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341836-105":59,"doc-detail-341836-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epigenetic-silencing-of-zic4-unveils-a-potential-tumor-suppressor-role-in-pediatric-choroid-plexus-carcinoma","Epigenetic silencing of ZIC4 unveils a potential tumor suppressor role in pediatric choroid plexus carcinoma","","Epigenetic regulation of the transcription factor ZIC4 in pediatric choroid plexus tumors (CPTs) is investigated using data mining and bioinformatics to link DNA methylation with patient survival. Results identify ZIC4 methylation as a stratifying factor, where hyper-methylation separates CPT cohorts into clusters and predicts adverse outcomes. Bisulfite sequencing confirms ZIC4 hyper-methylation in the CCHE-45 cell line, and demethylating and histone methyltransferase inhibitors reverse its silencing. RNA and proteomic profiling reveal immune, antigen presentation, ER stress, and metabolic pathway changes, while ZIC4 re-expression suppresses proliferation and migration, supporting ZIC4 hyper-methylation as a prognostic marker and tumor-suppressor mechanism.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epigenetic-silencing-of-zic4-unveils-a-potential-tumor-suppressor-role-in-pediatric-choroid-plexus-carcinoma/341836/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epigenetic-silencing-of-zic4-unveils-a-potential-tumor-suppressor-role-in-pediatric-choroid-plexus-carcinoma/341836.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the study relate ZIC4 methylation to patient outcomes in CPTs?","Question",{"text":112,"@type":113},"ZIC4 methylation is identified as a stratifying factor, dividing CPT cohorts into two clusters. Hyper-methylation is associated with adverse prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What experimental evidence confirms ZIC4 silencing in choroid plexus carcinoma cells?",{"text":117,"@type":113},"Hyper-methylation of ZIC4 is confirmed in the CCHE-45 cell line using bisulfite sequencing.",{"name":119,"@type":110,"acceptedAnswer":120},"How can ZIC4 silencing be reversed, and what functional effects follow?",{"text":121,"@type":113},"A demethylating agent and a histone methyltransferase inhibitor reverse ZIC4 silencing. Re-expressing ZIC4 negatively impacts cell proliferation and migration, alongside transcriptomic and proteomic pathway shifts.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341836,1790104427,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEpigenetic silencing of ZIC4 unveils a potential tumor suppressor role in pediatric choroid plexus carcinoma  \nDina Hesham1,2, Amal Mosaab1, Nada Amer1,2, NouranAl‑Shehaby1, Sameh Magdeldin3,4, Ahmed Hassan5, Hristo Georgiev5, Hisham Elshoky1, Mona Rady2,6, KhaledAbou Aisha2, Ola Sabet1,7 & Shahenda El‑Naggar1*  \nZic family member ZIC4 is a transcription factor that has been shown to be silenced in several cancers. However, understanding the regulation and function of ZIC4 in pediatric choroid plexus tumors (CPTs) remained limited. This study employed data mining and bioinformatics analysis to investigate the DNA methylation status of ZIC4 in CPTs and its correlation with patient survival. Our results unveiled ZIC4 methylation as a segregating factor, dividing CPT cohorts into two clusters, with hyper‑ methylation linked to adverse prognosis. Hyper‑methylation of ZIC4 was confirmed in a choroid plexus carcinoma‑derived cell line (CCHE‑45) by bisulfite sequencing. Furthermore, our study demonstrated that demethylating agent and a histone methyltransferase inhibitor could reverse ZIC4 silencing. RNA sequencing and proteomic analysis showed that ZIC4 over‑expression influenced genes and proteins involved in immune response, antigen processing and presentation, endoplasmic reticulum stress, and metabolism. Functionally, re‑expressing ZIC4 negatively impacted cell proliferation and migration. Ultimately, these findings underscore ZIC4 hyper‑methylation as a prognostic marker in CPTs and shed light on potential mechanisms underlying its tumor suppressor role in CPC. This insight paves the way for novel therapeutic targets in treating aggressive CPTs.  \nKeywords ZIC4, Pediatric choroid plexus carcinoma, Epigenetic silencing, Tumor suppressor, Transcriptomic profiling, Proteomic profiling  \nPediatric choroid plexus tumors (CPTs) are rare intraventricular central nervous system (CNS) neoplasms originating from the choroid plexus epithelium. They account for less than 1% of all intracranial tumors and 2–4% of brain tumors in children1. Typically, CPTs affect patients under three years of age, with 10 to 20% diagnosed within the first year of life2. According to the World Health Organization (WHO) classification, CPTs are classified into three grades: benign choroid plexus papilloma (CPP) (WHO grade I), the intermediate form atypical choroid plexus papilloma (ACPP) (WHO grade II), and the aggressive choroid plexus carcinoma (CPC) (WHO grade III)3. Current evidence supports the involvement of TP53, Notch signaling, and Sonic Hedgehog (Shh) in the pathogenesis of CPTs. However, the exact molecular mechanisms underlying CPT development remain largely uncharacterized4.  \nPediatric cancers can be considered as a consequence of disruptions to normal development. During embryonic development, many biological processes and cellular differentiation depend on epigenetic regulation5,6. Over the recent decades, an increasing amount of evidence supports the role of epigenetics in tumorigenesis, raising the possibility that understanding these epigenetic mechanisms may contribute to classification, risk stratification, and novel therapies7,8. Epigenetic silencing of tumor suppressors has been reported to induce  \n1Tumor Biology Research Program, Basic Research Unit, Research Department, Children’s Cancer Hospital in Egypt 57357, 1 Sekket El Emam, El Madbah El Kadeem Yard, Sayeda Zeinab, Cairo, Egypt. 2Microbiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo (GUC), Cairo, Egypt. 3Proteomics and Metabolomics Research Program, Basic Research Unit, Research Department, Children’s Cancer Hospital Egypt 57357, Cairo, Egypt. 4Department of Physiology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt. 5Institute of Immunology, Hannover Medical School, Hannover, Germany. 6Faculty of Biotechnology,","cbCaic2Ie5ECYjfy","https://ap.wps.com/l/cbCaic2Ie5ECYjfy","pdf",4555895,13,"English","# Background\n## Pediatric choroid plexus tumors and grades\n## Epigenetics in pediatric tumorigenesis\n# ZIC4 and rationale\n## ZIC gene family functions\n## Prior evidence of ZIC4 in cancers\n# Study approach and key findings","[{\"question\":\"How does the study relate ZIC4 methylation to patient outcomes in CPTs?\",\"answer\":\"ZIC4 methylation is identified as a stratifying factor, dividing CPT cohorts into two clusters. Hyper-methylation is associated with adverse prognosis.\"},{\"question\":\"What experimental evidence confirms ZIC4 silencing in choroid plexus carcinoma cells?\",\"answer\":\"Hyper-methylation of ZIC4 is confirmed in the CCHE-45 cell line using bisulfite sequencing.\"},{\"question\":\"How can ZIC4 silencing be reversed, and what functional effects follow?\",\"answer\":\"A demethylating agent and a histone methyltransferase inhibitor reverse ZIC4 silencing. Re-expressing ZIC4 negatively impacts cell proliferation and migration, alongside transcriptomic and proteomic pathway shifts.\"}]","Epigenetic silencing of ZIC4 unveils a potential tumor suppressor role in pediatric choroid plexus carcinoma | PDF",1790044087,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4816306ca8fea358764d8288ced15b84.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d61ae010e60e285b320a510794838e2c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f1df19af1d6876e6861386ae5503bef.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb99919d37649ccdd6057db2dbd6e475.webp",980,1287]